

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | synaptic vesicle exocytosis (GO:0016079) | 4.49480235 |
| 2 | neuron cell-cell adhesion (GO:0007158) | 4.45331828 |
| 3 | vocalization behavior (GO:0071625) | 4.21186004 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.10551464 |
| 5 | neuronal action potential propagation (GO:0019227) | 4.01991249 |
| 6 | protein localization to synapse (GO:0035418) | 3.89155385 |
| 7 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.80821985 |
| 8 | cellular ketone body metabolic process (GO:0046950) | 3.80072568 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.77312795 |
| 10 | detection of calcium ion (GO:0005513) | 3.62750725 |
| 11 | platelet dense granule organization (GO:0060155) | 3.59190307 |
| 12 | regulation of hexokinase activity (GO:1903299) | 3.57145670 |
| 13 | regulation of glucokinase activity (GO:0033131) | 3.57145670 |
| 14 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.56194692 |
| 15 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.54952814 |
| 16 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.49230112 |
| 17 | glutamate secretion (GO:0014047) | 3.48208005 |
| 18 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.45176390 |
| 19 | ketone body metabolic process (GO:1902224) | 3.44355532 |
| 20 | innervation (GO:0060384) | 3.39046630 |
| 21 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.38850954 |
| 22 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 3.37167936 |
| 23 | neuron-neuron synaptic transmission (GO:0007270) | 3.36144111 |
| 24 | exploration behavior (GO:0035640) | 3.31998966 |
| 25 | locomotory exploration behavior (GO:0035641) | 3.31846391 |
| 26 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 3.28555809 |
| 27 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.25394436 |
| 28 | nonmotile primary cilium assembly (GO:0035058) | 3.24873814 |
| 29 | positive regulation of glycolytic process (GO:0045821) | 3.24842813 |
| 30 | synaptic vesicle maturation (GO:0016188) | 3.23951624 |
| 31 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.22946308 |
| 32 | regulation of synaptic vesicle transport (GO:1902803) | 3.21875135 |
| 33 | regulation of vesicle fusion (GO:0031338) | 3.20391985 |
| 34 | synaptic transmission, glutamatergic (GO:0035249) | 3.20325188 |
| 35 | negative regulation of cation channel activity (GO:2001258) | 3.19999548 |
| 36 | postsynaptic membrane organization (GO:0001941) | 3.18698772 |
| 37 | neurotransmitter secretion (GO:0007269) | 3.14540103 |
| 38 | regulation of catecholamine uptake involved in synaptic transmission (GO:0051940) | 3.13195923 |
| 39 | regulation of dopamine uptake involved in synaptic transmission (GO:0051584) | 3.13195923 |
| 40 | positive regulation of synapse maturation (GO:0090129) | 3.12197917 |
| 41 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.11329525 |
| 42 | presynaptic membrane assembly (GO:0097105) | 3.10941001 |
| 43 | epithelial cilium movement (GO:0003351) | 3.10191975 |
| 44 | glutamate receptor signaling pathway (GO:0007215) | 3.09585697 |
| 45 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.09358114 |
| 46 | regulation of respiratory system process (GO:0044065) | 3.09092349 |
| 47 | dendritic spine morphogenesis (GO:0060997) | 3.07599348 |
| 48 | striatum development (GO:0021756) | 3.04635931 |
| 49 | glycerophospholipid catabolic process (GO:0046475) | 3.02366386 |
| 50 | positive regulation of protein autophosphorylation (GO:0031954) | 3.01078532 |
| 51 | long-term synaptic potentiation (GO:0060291) | 2.99881208 |
| 52 | magnesium ion transport (GO:0015693) | 2.98662724 |
| 53 | response to histamine (GO:0034776) | 2.98591011 |
| 54 | synaptic transmission, dopaminergic (GO:0001963) | 2.96952210 |
| 55 | dendrite development (GO:0016358) | 2.96910756 |
| 56 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.94974442 |
| 57 | regulation of synapse structural plasticity (GO:0051823) | 2.94482927 |
| 58 | negative regulation of dendrite development (GO:2000171) | 2.92950865 |
| 59 | intraciliary transport (GO:0042073) | 2.92728828 |
| 60 | behavioral fear response (GO:0001662) | 2.90184880 |
| 61 | behavioral defense response (GO:0002209) | 2.90184880 |
| 62 | positive regulation of vesicle fusion (GO:0031340) | 2.89582621 |
| 63 | insulin secretion (GO:0030073) | 2.86524797 |
| 64 | dopamine biosynthetic process (GO:0042416) | 2.86160973 |
| 65 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.85644785 |
| 66 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.83629316 |
| 67 | cilium movement (GO:0003341) | 2.83483847 |
| 68 | startle response (GO:0001964) | 2.83401567 |
| 69 | synaptic vesicle endocytosis (GO:0048488) | 2.82861250 |
| 70 | long-term memory (GO:0007616) | 2.82553258 |
| 71 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.81407188 |
| 72 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.81263011 |
| 73 | L-phenylalanine catabolic process (GO:0006559) | 2.81263011 |
| 74 | behavioral response to cocaine (GO:0048148) | 2.80204372 |
| 75 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.78230715 |
| 76 | neuron recognition (GO:0008038) | 2.78113548 |
| 77 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.77639712 |
| 78 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.77639712 |
| 79 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.77454059 |
| 80 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.76878520 |
| 81 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.76293043 |
| 82 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.76226819 |
| 83 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 2.74653217 |
| 84 | fear response (GO:0042596) | 2.73578429 |
| 85 | regulation of synapse maturation (GO:0090128) | 2.73313165 |
| 86 | neurotransmitter transport (GO:0006836) | 2.73170520 |
| 87 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.73119423 |
| 88 | gamma-aminobutyric acid transport (GO:0015812) | 2.73118588 |
| 89 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.72575553 |
| 90 | presynaptic membrane organization (GO:0097090) | 2.72561028 |
| 91 | endocrine pancreas development (GO:0031018) | 2.71827574 |
| 92 | protein localization to cilium (GO:0061512) | 2.70969695 |
| 93 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.70224914 |
| 94 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.70224914 |
| 95 | regulation of postsynaptic membrane potential (GO:0060078) | 2.69323882 |
| 96 | positive regulation of synapse assembly (GO:0051965) | 2.68696722 |
| 97 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.68638930 |
| 98 | layer formation in cerebral cortex (GO:0021819) | 2.68472257 |
| 99 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.68194223 |
| 100 | synapse assembly (GO:0007416) | 2.67660641 |
| 101 | chaperone-mediated protein transport (GO:0072321) | 2.66985353 |
| 102 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.66552482 |
| 103 | regulation of neurotransmitter uptake (GO:0051580) | 2.65998631 |
| 104 | regulation of cilium movement (GO:0003352) | 2.65792664 |
| 105 | protein prenylation (GO:0018342) | 2.64239346 |
| 106 | prenylation (GO:0097354) | 2.64239346 |
| 107 | dendritic spine organization (GO:0097061) | 2.64184454 |
| 108 | proline transport (GO:0015824) | 2.63776613 |
| 109 | epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287) | 2.63535923 |
| 110 | response to gravity (GO:0009629) | 2.62334683 |
| 111 | sleep (GO:0030431) | 2.61692931 |
| 112 | regulation of dopamine secretion (GO:0014059) | 2.61582314 |
| 113 | establishment of synaptic vesicle localization (GO:0097480) | 2.61359144 |
| 114 | synaptic vesicle transport (GO:0048489) | 2.61359144 |
| 115 | positive regulation of inositol phosphate biosynthetic process (GO:0060732) | 2.60522421 |
| 116 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.60157062 |
| 117 | regulation of neurotransmitter secretion (GO:0046928) | 2.59989069 |
| 118 | regulation of protein kinase A signaling (GO:0010738) | 2.59766465 |
| 119 | transmission of nerve impulse (GO:0019226) | 2.59297176 |
| 120 | nitric oxide mediated signal transduction (GO:0007263) | 2.58785682 |
| 121 | positive regulation of membrane potential (GO:0045838) | 2.58740573 |
| 122 | regulation of neurotransmitter transport (GO:0051588) | 2.58730954 |
| 123 | neuronal action potential (GO:0019228) | 2.58387525 |
| 124 | regulation of respiratory gaseous exchange (GO:0043576) | 2.58103810 |
| 125 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.57048980 |
| 126 | nucleobase catabolic process (GO:0046113) | 2.55573672 |
| 127 | artery smooth muscle contraction (GO:0014824) | 2.55374662 |
| 128 | dopamine transport (GO:0015872) | 2.54784688 |
| 129 | auditory receptor cell differentiation (GO:0042491) | 2.54436210 |
| 130 | type B pancreatic cell development (GO:0003323) | 2.49847381 |
| 131 | prostate gland growth (GO:0060736) | 2.48656759 |
| 132 | cilium organization (GO:0044782) | 2.48523908 |
| 133 | tonic smooth muscle contraction (GO:0014820) | 2.47541806 |
| 134 | peptidyl-cysteine modification (GO:0018198) | 2.46735364 |
| 135 | cilium assembly (GO:0042384) | 2.46221773 |
| 136 | L-fucose catabolic process (GO:0042355) | 2.45991601 |
| 137 | fucose catabolic process (GO:0019317) | 2.45991601 |
| 138 | L-fucose metabolic process (GO:0042354) | 2.45991601 |
| 139 | vascular smooth muscle contraction (GO:0014829) | 2.44093831 |
| 140 | negative regulation of complement activation (GO:0045916) | 2.43064333 |
| 141 | auditory behavior (GO:0031223) | 2.39548703 |
| 142 | polyol catabolic process (GO:0046174) | 2.38646485 |
| 143 | reflex (GO:0060004) | 2.35614338 |
| 144 | negative regulation of protein activation cascade (GO:2000258) | 2.35434143 |
| 145 | glycosphingolipid biosynthetic process (GO:0006688) | 2.33764404 |
| 146 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.33698363 |
| 147 | L-phenylalanine metabolic process (GO:0006558) | 2.33698363 |
| 148 | water-soluble vitamin biosynthetic process (GO:0042364) | 2.33164077 |
| 149 | nephron epithelium morphogenesis (GO:0072088) | 2.30502686 |
| 150 | nephron tubule morphogenesis (GO:0072078) | 2.30502686 |
| 151 | phenylpropanoid metabolic process (GO:0009698) | 2.30113324 |
| 152 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.29501708 |
| 153 | pancreas development (GO:0031016) | 2.28480261 |
| 154 | neurotransmitter uptake (GO:0001504) | 2.28161186 |
| 155 | regulation of male gonad development (GO:2000018) | 2.27855076 |
| 156 | axoneme assembly (GO:0035082) | 2.27076856 |
| 157 | bile acid biosynthetic process (GO:0006699) | 2.26782899 |
| 158 | protein neddylation (GO:0045116) | 2.25916697 |
| 159 | intra-Golgi vesicle-mediated transport (GO:0006891) | 2.25359736 |
| 160 | regulation of protein glycosylation (GO:0060049) | 2.25184466 |
| 161 | neuron fate determination (GO:0048664) | 2.24165856 |
| 162 | renal tubule morphogenesis (GO:0061333) | 2.23846804 |
| 163 | positive regulation of protein ubiquitination involved in ubiquitin-dependent protein catabolic proc | 2.21949510 |
| 164 | cilium morphogenesis (GO:0060271) | 2.20494415 |
| 165 | retinal metabolic process (GO:0042574) | 2.19927840 |
| 166 | zinc ion transport (GO:0006829) | 2.19814572 |
| 167 | limb bud formation (GO:0060174) | 2.18436039 |
| 168 | inner ear receptor cell differentiation (GO:0060113) | 2.17757229 |
| 169 | kidney morphogenesis (GO:0060993) | 2.14636301 |
| 170 | anterograde synaptic vesicle transport (GO:0048490) | 2.13647127 |
| 171 | sequestering of extracellular ligand from receptor (GO:0035581) | 2.13190057 |
| 172 | branched-chain amino acid catabolic process (GO:0009083) | 2.12575724 |
| 173 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.12473204 |
| 174 | detection of mechanical stimulus involved in sensory perception of sound (GO:0050910) | 2.12425042 |
| 175 | behavioral response to nicotine (GO:0035095) | 2.10559763 |
| 176 | brain morphogenesis (GO:0048854) | 2.09863034 |
| 177 | positive regulation of peptide hormone secretion (GO:0090277) | 2.09611175 |
| 178 | response to pheromone (GO:0019236) | 2.09209996 |
| 179 | melanosome transport (GO:0032402) | 2.08956490 |
| 180 | xenobiotic catabolic process (GO:0042178) | 2.08397966 |
| 181 | macroautophagy (GO:0016236) | 2.08295111 |
| 182 | righting reflex (GO:0060013) | 2.07866632 |
| 183 | beta-amyloid metabolic process (GO:0050435) | 2.05565871 |
| 184 | positive regulation of peptide secretion (GO:0002793) | 2.04924275 |
| 185 | establishment of melanosome localization (GO:0032401) | 2.04876993 |
| 186 | heme transport (GO:0015886) | 2.04746918 |
| 187 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.04577238 |
| 188 | cellular component assembly involved in morphogenesis (GO:0010927) | 2.04238584 |
| 189 | pigment granule transport (GO:0051904) | 2.04217002 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.50218309 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.88385771 |
| 3 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.82481007 |
| 4 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.75109325 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.71141040 |
| 6 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.63338189 |
| 7 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.47267702 |
| 8 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.39805264 |
| 9 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.38659511 |
| 10 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.38019246 |
| 11 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37879502 |
| 12 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.30459319 |
| 13 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.30459319 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.30086228 |
| 15 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.28870029 |
| 16 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.19776136 |
| 17 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.16458225 |
| 18 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 2.13520571 |
| 19 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.12369298 |
| 20 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 2.12109638 |
| 21 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.11734087 |
| 22 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 2.07584627 |
| 23 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 2.07526272 |
| 24 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.04965573 |
| 25 | P300_19829295_ChIP-Seq_ESCs_Human | 2.00447023 |
| 26 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.99050190 |
| 27 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.96886589 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.92384153 |
| 29 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.88134405 |
| 30 | FUS_26573619_Chip-Seq_HEK293_Human | 1.87487937 |
| 31 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.85193678 |
| 32 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.85163576 |
| 33 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.84939381 |
| 34 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.80840379 |
| 35 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.74384854 |
| 36 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.72786831 |
| 37 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.69091070 |
| 38 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.68870038 |
| 39 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.68675478 |
| 40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.68144906 |
| 41 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.65111805 |
| 42 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.64459284 |
| 43 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.63246389 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.61033800 |
| 45 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.57582035 |
| 46 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.54869929 |
| 47 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.49261343 |
| 48 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.49261343 |
| 49 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.48740264 |
| 50 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.47710316 |
| 51 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.47100740 |
| 52 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45801894 |
| 53 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.45223680 |
| 54 | AR_25329375_ChIP-Seq_VCAP_Human | 1.43205112 |
| 55 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.41591101 |
| 56 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.40093852 |
| 57 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.37705555 |
| 58 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.36226174 |
| 59 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.36108664 |
| 60 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.35366359 |
| 61 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.34990356 |
| 62 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.31759264 |
| 63 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.31617537 |
| 64 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.31532693 |
| 65 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.30883701 |
| 66 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.30525276 |
| 67 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.30404276 |
| 68 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.29479151 |
| 69 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.29404411 |
| 70 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.28429982 |
| 71 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.28133526 |
| 72 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.28130128 |
| 73 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.27695285 |
| 74 | STAT3_23295773_ChIP-Seq_U87_Human | 1.26865654 |
| 75 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.25763517 |
| 76 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 1.24535465 |
| 77 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.24518804 |
| 78 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.21428075 |
| 79 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.21193120 |
| 80 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.20081092 |
| 81 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.20039740 |
| 82 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.19803538 |
| 83 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.18729554 |
| 84 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.18729554 |
| 85 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.18600661 |
| 86 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18150198 |
| 87 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.17665234 |
| 88 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.17084262 |
| 89 | JUN_21703547_ChIP-Seq_K562_Human | 1.16794397 |
| 90 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.16554429 |
| 91 | RUNX2_22187159_ChIP-Seq_PCA_Human | 1.13158953 |
| 92 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.12883807 |
| 93 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.12465206 |
| 94 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.12081385 |
| 95 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.10686459 |
| 96 | EWS_26573619_Chip-Seq_HEK293_Human | 1.10421660 |
| 97 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.10376691 |
| 98 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.09929878 |
| 99 | CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.08881148 |
| 100 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.08492023 |
| 101 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07918714 |
| 102 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07843551 |
| 103 | CJUN_26792858_Chip-Seq_BT549_Human | 1.06041704 |
| 104 | TCF4_23295773_ChIP-Seq_U87_Human | 1.05835096 |
| 105 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.05267838 |
| 106 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.04483321 |
| 107 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.04008681 |
| 108 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.03393224 |
| 109 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.03188532 |
| 110 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.03127333 |
| 111 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.02416352 |
| 112 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.02379794 |
| 113 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.01809634 |
| 114 | P300_18555785_Chip-Seq_ESCs_Mouse | 1.01686139 |
| 115 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.01678165 |
| 116 | EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01548884 |
| 117 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.01125659 |
| 118 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.01057701 |
| 119 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.00499969 |
| 120 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.00499969 |
| 121 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 0.99777585 |
| 122 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 0.99576364 |
| 123 | SUZ12_18555785_Chip-Seq_ESCs_Mouse | 0.99113675 |
| 124 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.98646145 |
| 125 | FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.98580688 |
| 126 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.98068874 |
| 127 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 0.97896902 |
| 128 | KDM2B_26808549_Chip-Seq_REH_Human | 0.97360351 |
| 129 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 0.96995725 |
| 130 | SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95806982 |
| 131 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.95042392 |
| 132 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.95042392 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 4.08619780 |
| 2 | MP0003880_abnormal_central_pattern | 3.90813036 |
| 3 | MP0004270_analgesia | 3.29377137 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.13348460 |
| 5 | MP0001968_abnormal_touch/_nociception | 3.04880136 |
| 6 | MP0003195_calcinosis | 2.84001340 |
| 7 | MP0009745_abnormal_behavioral_response | 2.82931980 |
| 8 | MP0002736_abnormal_nociception_after | 2.75399335 |
| 9 | MP0002063_abnormal_learning/memory/cond | 2.68235324 |
| 10 | MP0002734_abnormal_mechanical_nocicepti | 2.62622848 |
| 11 | MP0002735_abnormal_chemical_nociception | 2.53483801 |
| 12 | MP0000569_abnormal_digit_pigmentation | 2.52017164 |
| 13 | MP0006276_abnormal_autonomic_nervous | 2.49410283 |
| 14 | MP0002572_abnormal_emotion/affect_behav | 2.46990040 |
| 15 | MP0002272_abnormal_nervous_system | 2.42175850 |
| 16 | MP0002064_seizures | 2.41936460 |
| 17 | MP0005646_abnormal_pituitary_gland | 2.37110971 |
| 18 | MP0001501_abnormal_sleep_pattern | 2.34291062 |
| 19 | MP0001529_abnormal_vocalization | 2.34054147 |
| 20 | MP0010386_abnormal_urinary_bladder | 2.26251648 |
| 21 | MP0002733_abnormal_thermal_nociception | 2.25083695 |
| 22 | MP0001188_hyperpigmentation | 2.20147537 |
| 23 | MP0009046_muscle_twitch | 2.19289867 |
| 24 | MP0002822_catalepsy | 2.14375151 |
| 25 | MP0001970_abnormal_pain_threshold | 2.12125794 |
| 26 | MP0002837_dystrophic_cardiac_calcinosis | 2.09824252 |
| 27 | MP0001486_abnormal_startle_reflex | 2.08628265 |
| 28 | MP0010678_abnormal_skin_adnexa | 2.00003961 |
| 29 | MP0001905_abnormal_dopamine_level | 1.99832724 |
| 30 | MP0002139_abnormal_hepatobiliary_system | 1.99306175 |
| 31 | MP0002067_abnormal_sensory_capabilities | 1.97707927 |
| 32 | MP0000383_abnormal_hair_follicle | 1.95678752 |
| 33 | MP0001984_abnormal_olfaction | 1.95289305 |
| 34 | MP0001986_abnormal_taste_sensitivity | 1.93334627 |
| 35 | MP0006292_abnormal_olfactory_placode | 1.87347037 |
| 36 | MP0005085_abnormal_gallbladder_physiolo | 1.81945684 |
| 37 | MP0003122_maternal_imprinting | 1.81878580 |
| 38 | MP0001440_abnormal_grooming_behavior | 1.79781081 |
| 39 | MP0003121_genomic_imprinting | 1.79639841 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.79156549 |
| 41 | MP0002184_abnormal_innervation | 1.77226984 |
| 42 | MP0002102_abnormal_ear_morphology | 1.76179726 |
| 43 | MP0005365_abnormal_bile_salt | 1.74086907 |
| 44 | MP0000778_abnormal_nervous_system | 1.73591502 |
| 45 | MP0008877_abnormal_DNA_methylation | 1.71303868 |
| 46 | MP0005423_abnormal_somatic_nervous | 1.70486318 |
| 47 | MP0005248_abnormal_Harderian_gland | 1.68373806 |
| 48 | MP0009780_abnormal_chondrocyte_physiolo | 1.68348081 |
| 49 | MP0004924_abnormal_behavior | 1.67364754 |
| 50 | MP0005386_behavior/neurological_phenoty | 1.67364754 |
| 51 | MP0006072_abnormal_retinal_apoptosis | 1.63785208 |
| 52 | MP0008875_abnormal_xenobiotic_pharmacok | 1.61224840 |
| 53 | MP0005645_abnormal_hypothalamus_physiol | 1.57898458 |
| 54 | MP0000013_abnormal_adipose_tissue | 1.51450277 |
| 55 | MP0003011_delayed_dark_adaptation | 1.48982954 |
| 56 | MP0000427_abnormal_hair_cycle | 1.47623244 |
| 57 | MP0002909_abnormal_adrenal_gland | 1.45720994 |
| 58 | MP0004885_abnormal_endolymph | 1.44471116 |
| 59 | MP0005220_abnormal_exocrine_pancreas | 1.36487646 |
| 60 | MP0003283_abnormal_digestive_organ | 1.36272876 |
| 61 | MP0010329_abnormal_lipoprotein_level | 1.33747373 |
| 62 | MP0004133_heterotaxia | 1.33721818 |
| 63 | MP0005379_endocrine/exocrine_gland_phen | 1.32493889 |
| 64 | MP0000955_abnormal_spinal_cord | 1.31427251 |
| 65 | MP0001502_abnormal_circadian_rhythm | 1.27302177 |
| 66 | MP0004215_abnormal_myocardial_fiber | 1.26979938 |
| 67 | MP0004811_abnormal_neuron_physiology | 1.25651962 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 1.21747442 |
| 69 | MP0000631_abnormal_neuroendocrine_gland | 1.21678943 |
| 70 | MP0002882_abnormal_neuron_morphology | 1.20966027 |
| 71 | MP0002090_abnormal_vision | 1.20797295 |
| 72 | MP0008569_lethality_at_weaning | 1.20309665 |
| 73 | MP0002638_abnormal_pupillary_reflex | 1.18881365 |
| 74 | MP0005408_hypopigmentation | 1.18393047 |
| 75 | MP0005551_abnormal_eye_electrophysiolog | 1.16988362 |
| 76 | MP0003879_abnormal_hair_cell | 1.12867588 |
| 77 | MP0002066_abnormal_motor_capabilities/c | 1.12336275 |
| 78 | MP0004147_increased_porphyrin_level | 1.11886782 |
| 79 | MP0008872_abnormal_physiological_respon | 1.09464341 |
| 80 | MP0001963_abnormal_hearing_physiology | 1.09181678 |
| 81 | MP0006054_spinal_hemorrhage | 1.08714494 |
| 82 | MP0000462_abnormal_digestive_system | 1.07146732 |
| 83 | MP0002928_abnormal_bile_duct | 1.06980088 |
| 84 | MP0004858_abnormal_nervous_system | 1.04666931 |
| 85 | MP0005187_abnormal_penis_morphology | 1.03981926 |
| 86 | MP0010234_abnormal_vibrissa_follicle | 1.03598616 |
| 87 | MP0004142_abnormal_muscle_tone | 1.03511571 |
| 88 | MP0002163_abnormal_gland_morphology | 1.03369407 |
| 89 | MP0008775_abnormal_heart_ventricle | 1.02709447 |
| 90 | MP0001756_abnormal_urination | 1.02652289 |
| 91 | MP0005171_absent_coat_pigmentation | 1.02588403 |
| 92 | MP0003252_abnormal_bile_duct | 1.01893776 |
| 93 | MP0002876_abnormal_thyroid_physiology | 1.01596595 |
| 94 | MP0000639_abnormal_adrenal_gland | 1.01457878 |
| 95 | MP0003868_abnormal_feces_composition | 1.01091153 |
| 96 | MP0001664_abnormal_digestion | 1.00964913 |
| 97 | MP0004742_abnormal_vestibular_system | 0.98175576 |
| 98 | MP0003329_amyloid_beta_deposits | 0.96210417 |
| 99 | MP0000516_abnormal_urinary_system | 0.94492778 |
| 100 | MP0005367_renal/urinary_system_phenotyp | 0.94492778 |
| 101 | MP0005332_abnormal_amino_acid | 0.93621380 |
| 102 | MP0003633_abnormal_nervous_system | 0.93345155 |
| 103 | MP0001270_distended_abdomen | 0.93191490 |
| 104 | MP0000647_abnormal_sebaceous_gland | 0.92962417 |
| 105 | MP0004019_abnormal_vitamin_homeostasis | 0.92418439 |
| 106 | MP0005084_abnormal_gallbladder_morpholo | 0.89651996 |
| 107 | MP0002152_abnormal_brain_morphology | 0.89370350 |
| 108 | MP0005394_taste/olfaction_phenotype | 0.89004327 |
| 109 | MP0005499_abnormal_olfactory_system | 0.89004327 |
| 110 | MP0002752_abnormal_somatic_nervous | 0.88841973 |
| 111 | MP0005409_darkened_coat_color | 0.87308096 |
| 112 | MP0003787_abnormal_imprinting | 0.86211486 |
| 113 | MP0002078_abnormal_glucose_homeostasis | 0.85484660 |
| 114 | MP0002295_abnormal_pulmonary_circulatio | 0.83135271 |
| 115 | MP0001324_abnormal_eye_pigmentation | 0.82784274 |
| 116 | MP0001666_abnormal_nutrient_absorption | 0.82607932 |
| 117 | MP0002069_abnormal_eating/drinking_beha | 0.82540434 |
| 118 | MP0005253_abnormal_eye_physiology | 0.82368666 |
| 119 | MP0003631_nervous_system_phenotype | 0.82338869 |
| 120 | MP0004484_altered_response_of | 0.81735196 |
| 121 | MP0002229_neurodegeneration | 0.81198577 |
| 122 | MP0003942_abnormal_urinary_system | 0.80586276 |
| 123 | MP0005174_abnormal_tail_pigmentation | 0.80344385 |
| 124 | MP0009250_abnormal_appendicular_skeleto | 0.78699501 |
| 125 | MP0000751_myopathy | 0.77982790 |
| 126 | MP0004043_abnormal_pH_regulation | 0.77741872 |
| 127 | MP0002751_abnormal_autonomic_nervous | 0.77614804 |
| 128 | MP0003634_abnormal_glial_cell | 0.77455556 |
| 129 | MP0009379_abnormal_foot_pigmentation | 0.77263664 |
| 130 | MP0008789_abnormal_olfactory_epithelium | 0.76618795 |
| 131 | MP0005535_abnormal_body_temperature | 0.75868125 |
| 132 | MP0001485_abnormal_pinna_reflex | 0.74272492 |
| 133 | MP0004085_abnormal_heartbeat | 0.72406180 |
| 134 | MP0000026_abnormal_inner_ear | 0.72354365 |
| 135 | MP0000230_abnormal_systemic_arterial | 0.70584561 |
| 136 | MP0000372_irregular_coat_pigmentation | 0.68760533 |
| 137 | MP0002693_abnormal_pancreas_physiology | 0.66567925 |
| 138 | MP0000681_abnormal_thyroid_gland | 0.65149683 |
| 139 | MP0003183_abnormal_peptide_metabolism | 0.63839402 |
| 140 | MP0003123_paternal_imprinting | 0.62717568 |
| 141 | MP0000534_abnormal_ureter_morphology | 0.62464191 |
| 142 | MP0001944_abnormal_pancreas_morphology | 0.61629950 |
| 143 | MP0002234_abnormal_pharynx_morphology | 0.60306400 |
| 144 | MP0002938_white_spotting | 0.59559146 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 5.67347820 |
| 2 | Hypothermia (HP:0002045) | 4.89712352 |
| 3 | Myokymia (HP:0002411) | 4.64806580 |
| 4 | Atonic seizures (HP:0010819) | 4.39959491 |
| 5 | Visual hallucinations (HP:0002367) | 3.98710847 |
| 6 | Epileptic encephalopathy (HP:0200134) | 3.83809817 |
| 7 | Focal seizures (HP:0007359) | 3.73176652 |
| 8 | Febrile seizures (HP:0002373) | 3.61396120 |
| 9 | Gait imbalance (HP:0002141) | 3.52397631 |
| 10 | Hypoglycemic coma (HP:0001325) | 3.47042280 |
| 11 | Medial flaring of the eyebrow (HP:0010747) | 3.38139430 |
| 12 | Congenital primary aphakia (HP:0007707) | 3.36373640 |
| 13 | Drooling (HP:0002307) | 3.36333557 |
| 14 | Excessive salivation (HP:0003781) | 3.36333557 |
| 15 | Acute necrotizing encephalopathy (HP:0006965) | 3.22123908 |
| 16 | Absence seizures (HP:0002121) | 3.20130041 |
| 17 | Genital tract atresia (HP:0001827) | 3.13431026 |
| 18 | Nephrogenic diabetes insipidus (HP:0009806) | 3.09745136 |
| 19 | Pancreatic cysts (HP:0001737) | 3.04345938 |
| 20 | Hyperventilation (HP:0002883) | 3.00624955 |
| 21 | Limb dystonia (HP:0002451) | 2.99972447 |
| 22 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.96491167 |
| 23 | Large for gestational age (HP:0001520) | 2.96340456 |
| 24 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.94663410 |
| 25 | Ketoacidosis (HP:0001993) | 2.91823286 |
| 26 | Pheochromocytoma (HP:0002666) | 2.90577488 |
| 27 | Vaginal atresia (HP:0000148) | 2.89295360 |
| 28 | Abnormality of midbrain morphology (HP:0002418) | 2.89031465 |
| 29 | Molar tooth sign on MRI (HP:0002419) | 2.89031465 |
| 30 | Agitation (HP:0000713) | 2.85838517 |
| 31 | Dialeptic seizures (HP:0011146) | 2.79407189 |
| 32 | Anxiety (HP:0000739) | 2.78809948 |
| 33 | Renal cortical cysts (HP:0000803) | 2.77747860 |
| 34 | Generalized tonic-clonic seizures (HP:0002069) | 2.77075868 |
| 35 | Progressive macrocephaly (HP:0004481) | 2.76434227 |
| 36 | Median cleft lip (HP:0000161) | 2.73553486 |
| 37 | Abnormality of the renal cortex (HP:0011035) | 2.70605956 |
| 38 | Progressive cerebellar ataxia (HP:0002073) | 2.69687334 |
| 39 | Hypoglycemic seizures (HP:0002173) | 2.64485225 |
| 40 | Progressive inability to walk (HP:0002505) | 2.63760334 |
| 41 | Hepatocellular necrosis (HP:0001404) | 2.60054936 |
| 42 | Neuroendocrine neoplasm (HP:0100634) | 2.53899352 |
| 43 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.52925811 |
| 44 | Papillary thyroid carcinoma (HP:0002895) | 2.52717084 |
| 45 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.51450333 |
| 46 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.51450333 |
| 47 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.45663464 |
| 48 | Thyroid carcinoma (HP:0002890) | 2.43975776 |
| 49 | Polyphagia (HP:0002591) | 2.43626926 |
| 50 | Acute encephalopathy (HP:0006846) | 2.43076139 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.39032693 |
| 52 | Tubulointerstitial nephritis (HP:0001970) | 2.39020473 |
| 53 | Nephronophthisis (HP:0000090) | 2.38701197 |
| 54 | Megalencephaly (HP:0001355) | 2.37098798 |
| 55 | Hyperglycemia (HP:0003074) | 2.35299664 |
| 56 | Methylmalonic acidemia (HP:0002912) | 2.34596166 |
| 57 | Intestinal atresia (HP:0011100) | 2.31071426 |
| 58 | Abnormality of salivation (HP:0100755) | 2.29468304 |
| 59 | Chronic hepatic failure (HP:0100626) | 2.29080500 |
| 60 | Bifid tongue (HP:0010297) | 2.28612642 |
| 61 | Pancreatic fibrosis (HP:0100732) | 2.28100575 |
| 62 | Broad-based gait (HP:0002136) | 2.26964704 |
| 63 | Abnormality of the renal medulla (HP:0100957) | 2.25603351 |
| 64 | Poor coordination (HP:0002370) | 2.23997618 |
| 65 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.21492504 |
| 66 | Abnormality of endocrine pancreas physiology (HP:0012093) | 2.21302675 |
| 67 | Abnormality of the pancreatic islet cells (HP:0006476) | 2.21302675 |
| 68 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.20789938 |
| 69 | Amblyopia (HP:0000646) | 2.19531859 |
| 70 | Inability to walk (HP:0002540) | 2.19153715 |
| 71 | Retinal dysplasia (HP:0007973) | 2.17585675 |
| 72 | Arthropathy (HP:0003040) | 2.15656211 |
| 73 | Ketosis (HP:0001946) | 2.15582555 |
| 74 | Impaired pain sensation (HP:0007328) | 2.13548647 |
| 75 | Abnormality of pain sensation (HP:0010832) | 2.13548647 |
| 76 | Abnormal hair whorl (HP:0010721) | 2.12438967 |
| 77 | Postural tremor (HP:0002174) | 2.11187304 |
| 78 | Specific learning disability (HP:0001328) | 2.09396623 |
| 79 | Abnormality of the corticospinal tract (HP:0002492) | 2.09346926 |
| 80 | Abnormal pancreas size (HP:0012094) | 2.09286994 |
| 81 | Cystic liver disease (HP:0006706) | 2.08885831 |
| 82 | Disproportionate short-trunk short stature (HP:0003521) | 2.08285609 |
| 83 | Mutism (HP:0002300) | 2.07538892 |
| 84 | Poor suck (HP:0002033) | 2.07454919 |
| 85 | Postaxial hand polydactyly (HP:0001162) | 2.07167837 |
| 86 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.06373431 |
| 87 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.05675635 |
| 88 | Delayed gross motor development (HP:0002194) | 2.05399817 |
| 89 | Proximal tubulopathy (HP:0000114) | 2.01876655 |
| 90 | Absent speech (HP:0001344) | 2.00191445 |
| 91 | Action tremor (HP:0002345) | 1.99644313 |
| 92 | Abnormality of methionine metabolism (HP:0010901) | 1.98309324 |
| 93 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 1.98167607 |
| 94 | Absent/shortened dynein arms (HP:0200106) | 1.98167607 |
| 95 | Short tibia (HP:0005736) | 1.97890175 |
| 96 | Broad foot (HP:0001769) | 1.97203511 |
| 97 | Type II lissencephaly (HP:0007260) | 1.96487033 |
| 98 | Abnormality of vitamin B metabolism (HP:0004340) | 1.96389710 |
| 99 | Furrowed tongue (HP:0000221) | 1.96211359 |
| 100 | Epileptiform EEG discharges (HP:0011182) | 1.95924117 |
| 101 | Male pseudohermaphroditism (HP:0000037) | 1.95138872 |
| 102 | Adrenal hypoplasia (HP:0000835) | 1.94713398 |
| 103 | Failure to thrive in infancy (HP:0001531) | 1.94482690 |
| 104 | Depression (HP:0000716) | 1.94452707 |
| 105 | Restlessness (HP:0000711) | 1.93699555 |
| 106 | True hermaphroditism (HP:0010459) | 1.93675094 |
| 107 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 1.92947444 |
| 108 | Growth hormone excess (HP:0000845) | 1.92866289 |
| 109 | Optic disc pallor (HP:0000543) | 1.91265206 |
| 110 | Metaphyseal dysplasia (HP:0100255) | 1.90961907 |
| 111 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 1.90457813 |
| 112 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 1.90457813 |
| 113 | Truncal ataxia (HP:0002078) | 1.90223893 |
| 114 | Abnormal ciliary motility (HP:0012262) | 1.89916464 |
| 115 | Hepatoblastoma (HP:0002884) | 1.89702235 |
| 116 | Neoplasm of the thyroid gland (HP:0100031) | 1.87621977 |
| 117 | Biliary tract neoplasm (HP:0100574) | 1.87196105 |
| 118 | Submucous cleft hard palate (HP:0000176) | 1.85639989 |
| 119 | Abnormal biliary tract morphology (HP:0012440) | 1.85463345 |
| 120 | Hemiparesis (HP:0001269) | 1.83364297 |
| 121 | Increased CSF lactate (HP:0002490) | 1.83168926 |
| 122 | Narrow nasal bridge (HP:0000446) | 1.83159675 |
| 123 | EEG with generalized epileptiform discharges (HP:0011198) | 1.83137312 |
| 124 | Widely spaced teeth (HP:0000687) | 1.82969069 |
| 125 | Protruding tongue (HP:0010808) | 1.82645721 |
| 126 | Hypomagnesemia (HP:0002917) | 1.82110891 |
| 127 | Hypoventilation (HP:0002791) | 1.81621976 |
| 128 | Symptomatic seizures (HP:0011145) | 1.81600310 |
| 129 | Psychosis (HP:0000709) | 1.80859235 |
| 130 | Abnormal respiratory motile cilium physiology (HP:0012261) | 1.79694353 |
| 131 | Hyperkalemia (HP:0002153) | 1.78933947 |
| 132 | Vascular calcification (HP:0004934) | 1.78658799 |
| 133 | Abnormality of vitamin metabolism (HP:0100508) | 1.78517202 |
| 134 | Hepatic necrosis (HP:0002605) | 1.77492495 |
| 135 | Abnormal biliary tract physiology (HP:0012439) | 1.75917910 |
| 136 | Bile duct proliferation (HP:0001408) | 1.75917910 |
| 137 | Short foot (HP:0001773) | 1.75878507 |
| 138 | Testicular neoplasm (HP:0010788) | 1.75778400 |
| 139 | Diplopia (HP:0000651) | 1.75709954 |
| 140 | Abnormality of binocular vision (HP:0011514) | 1.75709954 |
| 141 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.73088839 |
| 142 | Leukodystrophy (HP:0002415) | 1.72664618 |
| 143 | Vascular tortuosity (HP:0004948) | 1.71942519 |
| 144 | Generalized myoclonic seizures (HP:0002123) | 1.71736931 |
| 145 | Dysmetria (HP:0001310) | 1.71565395 |
| 146 | Arterial tortuosity (HP:0005116) | 1.71130441 |
| 147 | Thyroid-stimulating hormone excess (HP:0002925) | 1.70180969 |
| 148 | Patchy hypopigmentation of hair (HP:0011365) | 1.70148400 |
| 149 | Esotropia (HP:0000565) | 1.69924291 |
| 150 | Neoplasm of the adrenal cortex (HP:0100641) | 1.68740422 |
| 151 | Sex reversal (HP:0012245) | 1.68297134 |
| 152 | Abnormal sex determination (HP:0012244) | 1.68297134 |
| 153 | Epidermoid cyst (HP:0200040) | 1.68075918 |
| 154 | Torticollis (HP:0000473) | 1.67955139 |
| 155 | Neoplasm of the adrenal gland (HP:0100631) | 1.67709597 |
| 156 | Abolished electroretinogram (ERG) (HP:0000550) | 1.66903334 |
| 157 | Glycosuria (HP:0003076) | 1.66459876 |
| 158 | Abnormality of urine glucose concentration (HP:0011016) | 1.66459876 |
| 159 | X-linked dominant inheritance (HP:0001423) | 1.66229126 |
| 160 | Stereotypic behavior (HP:0000733) | 1.65701776 |
| 161 | Abnormal respiratory epithelium morphology (HP:0012253) | 1.65477490 |
| 162 | Abnormal respiratory motile cilium morphology (HP:0005938) | 1.65477490 |
| 163 | Hypsarrhythmia (HP:0002521) | 1.65027814 |
| 164 | Focal dystonia (HP:0004373) | 1.64030529 |
| 165 | Poor eye contact (HP:0000817) | 1.61091139 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.60693456 |
| 2 | MAP3K12 | 4.36741804 |
| 3 | CASK | 4.04285794 |
| 4 | NTRK3 | 3.51861600 |
| 5 | EPHA4 | 2.89684065 |
| 6 | MAP3K9 | 2.72242532 |
| 7 | MAP2K7 | 2.64502502 |
| 8 | ARAF | 2.60262702 |
| 9 | MAP4K2 | 2.53187713 |
| 10 | GRK5 | 2.44794392 |
| 11 | ERBB3 | 2.37463202 |
| 12 | MAP3K4 | 2.27598613 |
| 13 | ACVR1B | 2.12362552 |
| 14 | PINK1 | 2.11486603 |
| 15 | PLK2 | 2.10883586 |
| 16 | MAP3K2 | 2.07663626 |
| 17 | CDK19 | 2.00240665 |
| 18 | STK39 | 1.93902458 |
| 19 | FGFR2 | 1.92479626 |
| 20 | TRIM28 | 1.89779786 |
| 21 | CDK8 | 1.89678831 |
| 22 | KSR2 | 1.83560602 |
| 23 | MAP2K4 | 1.76427499 |
| 24 | MINK1 | 1.75733111 |
| 25 | MUSK | 1.74987843 |
| 26 | MAPK13 | 1.66637604 |
| 27 | GRK1 | 1.63593758 |
| 28 | STK38L | 1.52587714 |
| 29 | MARK1 | 1.40229254 |
| 30 | PAK3 | 1.39955852 |
| 31 | RIPK4 | 1.36059142 |
| 32 | BRAF | 1.35925590 |
| 33 | NUAK1 | 1.32511313 |
| 34 | NTRK1 | 1.32187867 |
| 35 | WNK3 | 1.30986620 |
| 36 | STK3 | 1.27762858 |
| 37 | OXSR1 | 1.25635300 |
| 38 | CAMKK2 | 1.22687557 |
| 39 | MAP3K13 | 1.22486624 |
| 40 | ADRBK2 | 1.19963244 |
| 41 | BMPR2 | 1.13946540 |
| 42 | PRKD3 | 1.13692323 |
| 43 | TRPM7 | 1.13107296 |
| 44 | CSNK1G1 | 1.11804329 |
| 45 | PTK2B | 1.09461579 |
| 46 | BRSK2 | 1.08708847 |
| 47 | TNIK | 1.07891831 |
| 48 | NTRK2 | 1.06690888 |
| 49 | AKT3 | 1.04799864 |
| 50 | LATS2 | 1.04595481 |
| 51 | CAMK2A | 1.04541783 |
| 52 | INSRR | 1.03408217 |
| 53 | MYLK | 1.02605363 |
| 54 | DAPK1 | 1.00487816 |
| 55 | SGK2 | 1.00442912 |
| 56 | CSNK1G3 | 0.97467248 |
| 57 | TAOK3 | 0.96352513 |
| 58 | CDK5 | 0.95877753 |
| 59 | SGK223 | 0.94321482 |
| 60 | SGK494 | 0.94321482 |
| 61 | YES1 | 0.94096975 |
| 62 | NME1 | 0.91752797 |
| 63 | PRKCE | 0.90335954 |
| 64 | MAP3K6 | 0.89925309 |
| 65 | DAPK2 | 0.89917121 |
| 66 | EIF2AK3 | 0.89148586 |
| 67 | PRKCG | 0.87816568 |
| 68 | BMPR1B | 0.87617434 |
| 69 | MAPKAPK3 | 0.86617079 |
| 70 | LMTK2 | 0.86155789 |
| 71 | LATS1 | 0.84232121 |
| 72 | MAP3K1 | 0.84200941 |
| 73 | CAMK2D | 0.82563562 |
| 74 | KSR1 | 0.82356209 |
| 75 | RPS6KA2 | 0.82269007 |
| 76 | HIPK2 | 0.79380428 |
| 77 | PHKG1 | 0.77753483 |
| 78 | PHKG2 | 0.77753483 |
| 79 | CAMK2B | 0.75385926 |
| 80 | MOS | 0.74044273 |
| 81 | UHMK1 | 0.72950050 |
| 82 | RET | 0.72675885 |
| 83 | ERBB4 | 0.72412643 |
| 84 | MAPKAPK5 | 0.72398324 |
| 85 | PNCK | 0.71933144 |
| 86 | FER | 0.71078395 |
| 87 | MET | 0.70640830 |
| 88 | PDK3 | 0.70074994 |
| 89 | PDK4 | 0.70074994 |
| 90 | FES | 0.69041486 |
| 91 | STK16 | 0.68717556 |
| 92 | MKNK1 | 0.67917428 |
| 93 | CSNK1G2 | 0.67640635 |
| 94 | PAK6 | 0.66663190 |
| 95 | ILK | 0.66352691 |
| 96 | MAP2K1 | 0.65951353 |
| 97 | LIMK1 | 0.65522087 |
| 98 | EPHA3 | 0.65054484 |
| 99 | CAMK1 | 0.62222944 |
| 100 | CCNB1 | 0.62161304 |
| 101 | PRKCH | 0.62157712 |
| 102 | RAF1 | 0.60966257 |
| 103 | PLK3 | 0.59832564 |
| 104 | ADRBK1 | 0.58405820 |
| 105 | MKNK2 | 0.58160502 |
| 106 | FGFR3 | 0.57817732 |
| 107 | DYRK1A | 0.57537040 |
| 108 | SIK3 | 0.57279061 |
| 109 | CSNK1A1L | 0.55596696 |
| 110 | PDK1 | 0.53816903 |
| 111 | PRKG1 | 0.53088609 |
| 112 | PDPK1 | 0.52906025 |
| 113 | MARK2 | 0.52324715 |
| 114 | CDK14 | 0.51808875 |
| 115 | PRPF4B | 0.48567480 |
| 116 | BCKDK | 0.48401955 |
| 117 | CDK18 | 0.47975426 |
| 118 | MAPK15 | 0.47817867 |
| 119 | RPS6KA6 | 0.47786396 |
| 120 | FGR | 0.46103798 |
| 121 | DYRK2 | 0.45843538 |
| 122 | MST4 | 0.45432004 |
| 123 | SGK1 | 0.45414265 |
| 124 | MAP2K2 | 0.45210410 |
| 125 | PIK3CA | 0.45059169 |
| 126 | CSNK1A1 | 0.44946054 |
| 127 | PRKAA1 | 0.44324240 |
| 128 | EIF2AK1 | 0.43554469 |
| 129 | GRK7 | 0.43328492 |
| 130 | WNK1 | 0.43115765 |
| 131 | PRKACA | 0.43107166 |
| 132 | ERBB2 | 0.41856562 |
| 133 | CDK15 | 0.41684616 |
| 134 | PRKAA2 | 0.40352249 |
| 135 | FGFR1 | 0.40284137 |
| 136 | CAMKK1 | 0.40277483 |
| 137 | WNK4 | 0.39924256 |
| 138 | BCR | 0.39832855 |
| 139 | WEE1 | 0.39153815 |
| 140 | PASK | 0.38835837 |
| 141 | TGFBR1 | 0.38445708 |
| 142 | NLK | 0.37333445 |
| 143 | ROCK1 | 0.36345030 |
| 144 | FLT3 | 0.35325022 |
| 145 | PKN2 | 0.34720869 |
| 146 | BMX | 0.34630457 |
| 147 | PRKACB | 0.33948130 |
| 148 | PRKCZ | 0.33912339 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.42956793 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.08467658 |
| 3 | Circadian entrainment_Homo sapiens_hsa04713 | 2.58307332 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.53780349 |
| 5 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.53285385 |
| 6 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.50951937 |
| 7 | GABAergic synapse_Homo sapiens_hsa04727 | 2.44932971 |
| 8 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.42487770 |
| 9 | Olfactory transduction_Homo sapiens_hsa04740 | 2.36123265 |
| 10 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.33861672 |
| 11 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.23992062 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.21719963 |
| 13 | Morphine addiction_Homo sapiens_hsa05032 | 2.18407995 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 2.17380763 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 2.15568522 |
| 16 | Taste transduction_Homo sapiens_hsa04742 | 2.11651498 |
| 17 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.10734418 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 2.01459205 |
| 19 | Parkinsons disease_Homo sapiens_hsa05012 | 2.00680545 |
| 20 | Alzheimers disease_Homo sapiens_hsa05010 | 1.97098894 |
| 21 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.95835414 |
| 22 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.82762340 |
| 23 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.78249176 |
| 24 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.77060904 |
| 25 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.74582964 |
| 26 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.66069246 |
| 27 | Cocaine addiction_Homo sapiens_hsa05030 | 1.65031177 |
| 28 | Salivary secretion_Homo sapiens_hsa04970 | 1.62589420 |
| 29 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.62469942 |
| 30 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.61245205 |
| 31 | Renin secretion_Homo sapiens_hsa04924 | 1.61075272 |
| 32 | Long-term depression_Homo sapiens_hsa04730 | 1.57908176 |
| 33 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.50785192 |
| 34 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.48581918 |
| 35 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.46301853 |
| 36 | Peroxisome_Homo sapiens_hsa04146 | 1.45333581 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.42812566 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.41609217 |
| 39 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.38649072 |
| 40 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.35797706 |
| 41 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.34287700 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.33543109 |
| 43 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.33238797 |
| 44 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.32655003 |
| 45 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29449188 |
| 46 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.26944886 |
| 47 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.24740960 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.24305322 |
| 49 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.22386786 |
| 50 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.20264951 |
| 51 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.17605623 |
| 52 | Phototransduction_Homo sapiens_hsa04744 | 1.16541729 |
| 53 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.16178982 |
| 54 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.12749567 |
| 55 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.12551320 |
| 56 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.11566083 |
| 57 | Retinol metabolism_Homo sapiens_hsa00830 | 1.08930192 |
| 58 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.08269004 |
| 59 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.05951977 |
| 60 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.05899795 |
| 61 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.04959970 |
| 62 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.04931796 |
| 63 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.03583359 |
| 64 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.02949880 |
| 65 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 1.01247938 |
| 66 | Protein export_Homo sapiens_hsa03060 | 0.99386134 |
| 67 | Mineral absorption_Homo sapiens_hsa04978 | 0.99212363 |
| 68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.98642224 |
| 69 | Gap junction_Homo sapiens_hsa04540 | 0.97831990 |
| 70 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.95562928 |
| 71 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.95498397 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.94188389 |
| 73 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.93540342 |
| 74 | Circadian rhythm_Homo sapiens_hsa04710 | 0.93373778 |
| 75 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.91050697 |
| 76 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.90527463 |
| 77 | Histidine metabolism_Homo sapiens_hsa00340 | 0.89671780 |
| 78 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88612897 |
| 79 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.88581385 |
| 80 | Melanogenesis_Homo sapiens_hsa04916 | 0.87233070 |
| 81 | ABC transporters_Homo sapiens_hsa02010 | 0.87115573 |
| 82 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.84982639 |
| 83 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.82199644 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.82159465 |
| 85 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.82045622 |
| 86 | Bile secretion_Homo sapiens_hsa04976 | 0.81080329 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.80870110 |
| 88 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.80668195 |
| 89 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.78921316 |
| 90 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.77380494 |
| 91 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.76923985 |
| 92 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.76907828 |
| 93 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.76546467 |
| 94 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.75652128 |
| 95 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.75228704 |
| 96 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.74483618 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.74018098 |
| 98 | Axon guidance_Homo sapiens_hsa04360 | 0.72050630 |
| 99 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.72013653 |
| 100 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.70111012 |
| 101 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.68063635 |
| 102 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.67003588 |
| 103 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.66531366 |
| 104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.66444509 |
| 105 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.66431115 |
| 106 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.66188441 |
| 107 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.65810967 |
| 108 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61886396 |
| 109 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.61813740 |
| 110 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.61774308 |
| 111 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.59648232 |
| 112 | Glioma_Homo sapiens_hsa05214 | 0.59430370 |
| 113 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.58175397 |
| 114 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58151412 |
| 115 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.58041044 |
| 116 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.56715165 |
| 117 | Basal transcription factors_Homo sapiens_hsa03022 | 0.55983263 |
| 118 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.53958351 |
| 119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.51601943 |
| 120 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.51378625 |
| 121 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.50580653 |
| 122 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.49996345 |
| 123 | Metabolic pathways_Homo sapiens_hsa01100 | 0.48962556 |
| 124 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48879274 |
| 125 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48647292 |
| 126 | Alcoholism_Homo sapiens_hsa05034 | 0.48536772 |
| 127 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.45629531 |
| 128 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.45387520 |
| 129 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45184468 |
| 130 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.44738650 |
| 131 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.42803855 |
| 132 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42692431 |
| 133 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.41969282 |
| 134 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41550789 |
| 135 | Melanoma_Homo sapiens_hsa05218 | 0.40175639 |
| 136 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.38574839 |
| 137 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37867913 |
| 138 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.36019209 |
| 139 | Phagosome_Homo sapiens_hsa04145 | 0.34343133 |
| 140 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.34273163 |
| 141 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.33778058 |
| 142 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.33460098 |
| 143 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.32782261 |
| 144 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.30384796 |
| 145 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.30099573 |
| 146 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28846304 |
| 147 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.27234841 |
| 148 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.27083823 |
| 149 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.26824767 |
| 150 | Prion diseases_Homo sapiens_hsa05020 | 0.24574824 |
| 151 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.23483245 |

